<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000559076"><TermName>PAR-101</TermName><TermDefinition><DefinitionText>A substance being studied in the treatment of diarrhea caused by infection with <ScientificName>Clostridium difficile</ScientificName> (a type of bacteria that can grow without oxygen) in cancer patients. PAR-101 is a type of antibiotic. Also called OPT-80 and tiacumicin B.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>PAR-101</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de la diarrea causada por una infección por <ScientificName>Clostridium difficile</ScientificName> (un tipo de bacteria que puede crecer sin oxígeno) en los pacientes de cáncer. PAR-101 es un tipo de antibiótico. También se llama OPT-80 y tiacumicina B.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-07-06</DateFirstPublished><DateLastModified>2007-07-17</DateLastModified></GlossaryTerm>
